PRESS RELEASE published on 11/04/2025 at 22:05, 3 months 5 days ago In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees Evotec SE Payments Biosimilars Agreement Sandoz
BRIEF published on 10/29/2025 at 09:50, 3 months 12 days ago Evotec SE publiera ses résultats financiers du troisième trimestre 2025 le 5 novembre. Résultats Financiers Evotec SE Conférence Téléphonique Sciences De La Vie Performances 2025
BRIEF published on 10/29/2025 at 09:50, 3 months 12 days ago Evotec SE to Release Q3 2025 Financial Results on November 5th Financial Results Conference Call Life Sciences Evotec SE 2025 Performance
PRESS RELEASE published on 10/29/2025 at 09:45, 3 months 12 days ago Evotec SE to announce results for the first nine months 2025 on 05 November 2025 Evotec SE to announce results for the first nine months 2025 on 05 November 2025. The Company will hold a conference call in English to discuss the interim statement Conference Call Financial Report Evotec SE Results Interim Statement
BRIEF published on 10/27/2025 at 07:35, 3 months 14 days ago Evotec progresse dans le partenariat en neurosciences avec Bristol Myers Squibb Partenariat Neuroscience Evotec Bristol Myers Squibb Neurodégénératif
BRIEF published on 10/27/2025 at 07:35, 3 months 14 days ago Evotec Advances in Neuroscience Partnership with Bristol Myers Squibb Partnership Neuroscience Evotec Bristol Myers Squibb Neurodegenerative
PRESS RELEASE published on 10/27/2025 at 07:30, 3 months 14 days ago Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb Evotec SE announces US$ 25 m payment from Bristol Myers Squibb for progress in preclinical neuroscience partnership, advancing research on neurodegenerative diseases Partnership Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Research Progress
BRIEF published on 08/13/2025 at 07:05, 5 months 28 days ago Evotec SE publie ses résultats du premier semestre 2025, soulignant les progrès stratégiques Evotec SE Performance Financière Croissance Stratégique Développement De Produits Biologiques Résultats Du Premier Semestre 2025
BRIEF published on 08/13/2025 at 07:05, 5 months 28 days ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 5 months 28 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
Published on 02/10/2026 at 15:30, 4 hours 1 minute ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 4 hours 31 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 5 hours 1 minute ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 5 hours 31 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 19:07, 24 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 19:06, 25 minutes ago EQS-Adhoc: Wacker Neuson Group publishes preliminary financial year 2025 figures
Published on 02/10/2026 at 19:05, 26 minutes ago Quantifind Can Unlock Up to $177.9M in Annual Compliance Efficiency for Tier 1 Banks According to Celent Report
Published on 02/10/2026 at 18:52, 39 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/10/2026 at 18:01, 1 hour 30 minutes ago EuroTeleSites Fulfills 2025 Guidance: Revenue Grows and Rises to 280.2 mEUR; Deleveraging Down to 5.5x
Published on 02/10/2026 at 18:24, 1 hour 6 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 1 hour 6 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 1 hour 31 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 1 hour 31 minutes ago CIS wins several strategic contracts in Africa, South America and Asia
